Publication | Open Access
Aspirin or Rivaroxaban for VTE Prophylaxis after Hip or Knee Arthroplasty
428
Citations
14
References
2018
Year
Among patients who received 5 days of rivaroxaban prophylaxis after total hip or total knee arthroplasty, extended prophylaxis with aspirin was not significantly different from rivaroxaban in the prevention of symptomatic venous thromboembolism. (Funded by the Canadian Institutes of Health Research; ClinicalTrials.gov number, NCT01720108 .).
| Year | Citations | |
|---|---|---|
Page 1
Page 1